Who owns ANBIO BIOTECHNOLOGY?
- Ticker: NNNN
- CUSIP Number: g0367b105
Tip: Access positions for across all investors
Analyze quarterly positions in Anbio Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Anbio Biotechnology stock
Who bought or sold ANBIO BIOTECHNOLOGY this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 27k | $367k | 4% | Jun 2026 |
|
| Bank of America Corporation | 13k | $184k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 12k | $162k | 13% | Jun 2026 |
|
| Marshall Wace | 12k | $158k | 100% | Jun 2026 |
|
| Morgan Stanley | 7.3k | $189k | 26107% | Mar 2026 |
|
| UBS Group | 828.00 | $11k | -87% | Jun 2026 |
|
| EverSource Wealth Advisors | 187.00 | $2.6k | -30% | Jun 2026 |
|
| Advisor Group Holdings | 77.00 | $1.1k | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 53.00 | $718.001600 | 100% | Jun 2026 |
|
| Bare Financial Services | 15.00 | $205.999500 | 0% | Jun 2026 |
|
| Larson Financial Group | 5.00 | $69.000000 | 100% | Jun 2026 |
|
| Silver Grove Financial Group | 4.00 | $55.000000 | 100% | Jun 2026 |
|
Who sold out of Anbio Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wells Fargo & Company | Mar 2026 | 100.00 | $2.6k |
| Ronald Blue Trust | Mar 2026 | 5.00 | $128.000000 |